Clinical Trials
3 trialsNCT02429427 2020-06-23
REACT
Imperial College London
Phase 3 Completed
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00525096 2011-06-30
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 3 Completed